A Phase I Safety and Immunogenicity Dose Escalation Trial of Plague Vaccine, Flagellin/F1/V, In Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Yersinia pestis vaccine (Primary)
- Indications Plague; Yersinia infections
- Focus Adverse reactions; Pharmacodynamics
- 23 Oct 2014 Status changed from 'active, no longer recruiting' to 'completed' as reported by ClinicalTrials.gov record.
- 15 Jan 2014 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov
- 15 Aug 2013 Planned end date changed from 1 Jul 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.